Efficacy and Safety of Different Dosages of Anlotinib Combined with PD-1 Monoclonal Antibody in the Treatment of Advanced Non-Small Cell Lung Cancer
{{output}}
Objective: This study investigates the efficacy and safety of anlotinib in combination with PD-1 monoclonal antibody across different dosing regimens for advanced non-small cell lung cancer (NSCLC). It aims to determine whether a... ...
